The structural basis for autoinhibition of FLT3 by the juxtamembrane domain.
Griffith, J., Black, J., Faerman, C., Swenson, L., Wynn, M., Lu, F., Lippke, J., Saxena, K.(2004) Mol Cell 13: 169-178
- PubMed: 14759363 
- DOI: 10.1016/s1097-2765(03)00505-7
- Primary Citation of Related Structures:  
1RJB - PubMed Abstract: 
FLT3 is a type III receptor tyrosine kinase that is thought to play a key role in hematopoiesis. Certain classes of FLT3 mutations cause constitutively activated forms of the receptor that are found in significant numbers of patients with acute myelogenous leukemia (AML) ...